← UPST Overview
10-KFebruary 10, 20262/10/26· Fiscal Year Ended December 31, 2025· FY-End 12/31/25
UPST — 10-K Filing
Track for AlertsFinancial Highlights
Structured-data extract from the filer's SEC-tagged XBRL. Every value below is sourced from a labeled XBRL concept; hover any cell to see the exact source. No AI summarization, no paraphrasing.
Income Statement
| Item | Dec 31, 2025 | Dec 31, 2024 | YoY |
|---|---|---|---|
| Revenue | $1.04B | $636.53M | ↑ +64.0% |
| Cost of Revenue | — | — | |
| Operating Income (Loss) | $42.63M | −$172.86M | ↑ +124.7% |
| Net Loss from Continuing Operations(derived) | $53.60M | −$128.58M | ↑ +141.7% |
| Net Income (Loss) — Total | $53.60M | −$128.58M | ↑ +141.7% |
Balance Sheet
| Item | Dec 31, 2025 | Dec 31, 2024 | YoY |
|---|---|---|---|
| Total Assets | $2.97B | $2.37B | |
| Total Liabilities | $2.18B | $1.73B | |
| Stockholders' Equity | $798.82M | $633.22M | ↑ +26.2% |
| Accumulated Deficit | −$357.56M | −$411.16M | |
| Cash and Cash Equivalents | $652.39M | $788.42M | ↓ -17.3% |
| Shares Outstanding | 98.03M | 93.47M |
Cash Flow
| Item | Dec 31, 2025 | Dec 31, 2024 | YoY |
|---|---|---|---|
| Operating Cash Flow | −$147.72M | $186.33M | ↓ -179.3% |
Source filings — every value above is extracted verbatim from these SEC submissions:
- 10-Q filed 2026-05-05 · view on EDGAR
- DEF 14A filed 2026-04-16 · view on EDGAR
- 10-K filed 2026-02-10 · view on EDGAR
Current DredgeCap Risk Profile
5.5/10
ELEVATED RISK
Dilution Risk
MODERATE3.5/10
Liquidity Risk
MODERATE4.0/10
Debt Toxicity
ELEVATED5.0/10
Profitability Risk
ELEVATED5.5/10
Going Concern✓ Not flagged
The risk profile above reflects the latest cached DredgeCap analysis for UPST. For the full filing-by-filing analyst report (red flags, primary risk driver, what moves the stock), open UPST's company page.
What is a 10-K?
An annual report providing a comprehensive overview of the company's business and financial condition. Includes audited financial statements (signed off by an independent PCAOB-registered accounting firm), Risk Factors, Business description, MD&A, and disclosures about legal proceedings, controls, and corporate governance. The 10-K is the most important filing in US public-company disclosure.
Form-type explainers and 8-K item descriptions are derived from SEC documentation. Financial values are extracted from SEC-tagged XBRL — see the "Source filings" list above each table for direct EDGAR links to every cited filing. This page does not constitute investment advice. Always consult the original filing on SEC EDGAR for authoritative content, and consult a licensed financial advisor for investment decisions.